Literature DB >> 22046491

TTF-1 positive small cell cancers: Don't think they're always primary pulmonary!

Laurine Verset1, Marianna Arvanitakis, Patricia Loi, Jean Closset, Myriam Delhaye, Myriam Remmelink, Pieter Demetter.   

Abstract

Thyroid transcription factor 1 (TTF-1) plays a key role in morphogenesis of the lungs and is expressed in up to 90% of pulmonary small cell carcinomas. This explains why this marker is frequently used in the search for the primary origin of metastatic endocrine tumours. Here we report on a TTF-1 expressing mixed endocrine-exocrine carcinoma of the common bile duct in a patient with pulmonary nodules that did not appear to be neoplastic. TTF-1 positivity in pulmonary and extrapulmonary neuroendocrine tumours is reviewed, and we conclude that TTF-1 expression in neuroendocrine tumours of the small-cell type are not uncommon at extrapulmonary locations. Therefore, immunohistochemistry for TTF-1 in such tumours should be interpreted with caution.

Entities:  

Keywords:  Common bile duct; Immunohistochemistry; Mixed endocrine-exocrine tumour; Small cell carcinoma; Thyroid transcription factor 1

Year:  2011        PMID: 22046491      PMCID: PMC3205113          DOI: 10.4251/wjgo.v3.i10.144

Source DB:  PubMed          Journal:  World J Gastrointest Oncol


  22 in total

1.  Usefulness of CDX2 and TTF-1 in differentiating gastrointestinal from pulmonary carcinoids.

Authors:  Anjali Saqi; Diane Alexis; Fabrizio Remotti; Govind Bhagat
Journal:  Am J Clin Pathol       Date:  2005-03       Impact factor: 2.493

2.  Thyroid transcription factor-1 distinguishes metastatic pulmonary from well-differentiated neuroendocrine tumors of other sites.

Authors:  A M Oliveira; H D Tazelaar; J L Myers; L A Erickson; R V Lloyd
Journal:  Am J Surg Pathol       Date:  2001-06       Impact factor: 6.394

3.  Thyroid transcription factor-1 is expressed in extrapulmonary small cell carcinomas but not in other extrapulmonary neuroendocrine tumors.

Authors:  S N Agoff; L W Lamps; A T Philip; M B Amin; R A Schmidt; L D True; A L Folpe
Journal:  Mod Pathol       Date:  2000-03       Impact factor: 7.842

4.  Immunostaining for thyroid transcription factor 1 and cytokeratin 20 aids the distinction of small cell carcinoma from Merkel cell carcinoma, but not pulmonary from extrapulmonary small cell carcinomas.

Authors:  W Cheuk; M Y Kwan; S Suster; J K Chan
Journal:  Arch Pathol Lab Med       Date:  2001-02       Impact factor: 5.534

Review 5.  Transcriptional control of lung morphogenesis.

Authors:  Yutaka Maeda; Vrushank Davé; Jeffrey A Whitsett
Journal:  Physiol Rev       Date:  2007-01       Impact factor: 37.312

6.  TTF-1 expression is specific for lung primary in typical and atypical carcinoids: TTF-1-positive carcinoids are predominantly in peripheral location.

Authors:  Emma Z Du; P Goldstraw; Jo Zacharias; Olivier Tiffet; Paul J Craig; Andrew G Nicholson; Noel Weidner; Eunhee S Yi
Journal:  Hum Pathol       Date:  2004-07       Impact factor: 3.466

Review 7.  Small-cell carcinoma in the common bile duct treated with multidisciplinary management.

Authors:  Yukiyasu Okamura; Atsuyuki Maeda; Kazuya Matsunaga; Hideyuki Kanemoto; Narikazu Boku; Hiroyoshi Furukawa; Keiko Sasaki; Katsuhiko Uesaka
Journal:  J Hepatobiliary Pancreat Surg       Date:  2009-03-14

8.  Thyroid transcription factor-1: immunohistochemical evaluation in pulmonary neuroendocrine tumors.

Authors:  A L Folpe; A M Gown; L W Lamps; R Garcia; D H Dail; R J Zarbo; R A Schmidt
Journal:  Mod Pathol       Date:  1999-01       Impact factor: 7.842

9.  Immunohistochemical staining for CDX-2, PDX-1, NESP-55, and TTF-1 can help distinguish gastrointestinal carcinoid tumors from pancreatic endocrine and pulmonary carcinoid tumors.

Authors:  Amitabh Srivastava; Jason L Hornick
Journal:  Am J Surg Pathol       Date:  2009-04       Impact factor: 6.394

10.  Primary small cell carcinoma of the esophagus: clinicopathological and immunohistochemical features of 21 cases.

Authors:  Jing-Ping Yun; Mei-Fang Zhang; Jin-Hui Hou; Qiu-Hong Tian; Jia Fu; Xiao-Man Liang; Qiu-Liang Wu; Tie-Hua Rong
Journal:  BMC Cancer       Date:  2007-03-03       Impact factor: 4.430

View more
  7 in total

Review 1.  Immunohistochemical Biomarkers of Gastrointestinal, Pancreatic, Pulmonary, and Thymic Neuroendocrine Neoplasms.

Authors:  Silvia Uccella; Stefano La Rosa; Marco Volante; Mauro Papotti
Journal:  Endocr Pathol       Date:  2018-06       Impact factor: 3.943

2.  SOX2 and Rb1 in esophageal small-cell carcinoma: their possible involvement in pathogenesis.

Authors:  Hirotaka Ishida; Atsuko Kasajima; Takashi Kamei; Tsuyoshi Miura; Naomi Oka; Samaneh Yazdani; Yohei Ozawa; Fumiyoshi Fujishima; Akira Sakurada; Yasuhiro Nakamura; Yoichi Tanaka; Masafumi Kurosumi; Yuichi Ishikawa; Yoshinori Okada; Noriaki Ohuchi; Hironobu Sasano
Journal:  Mod Pathol       Date:  2017-01-20       Impact factor: 7.842

3.  Endoscopic-ultrasound-guided fine-needle aspiration and the role of the cytopathologist in solid pancreatic lesion diagnosis.

Authors:  Shahzad Iqbal; David Friedel; Mala Gupta; Lorna Ogden; Stavros N Stavropoulos
Journal:  Patholog Res Int       Date:  2012-05-15

4.  Primary Mediastinal Small Cell Neuroendocrine Carcinoma Presenting with Superior Vena Cava Syndrome.

Authors:  Lina R Costanzo; Tariq Kewan; Kevin Kerwin; Hamed Daw
Journal:  Cureus       Date:  2019-06-10

5.  Concurrence of hemophagocytic lymphohistiocytosis and small-cell lung cancer in bone marrow: A case report and literature review.

Authors:  Wenyan Xu; Zhenxing Guo
Journal:  SAGE Open Med Case Rep       Date:  2022-03-22

6.  Primary Malignant Neuroendocrine Tumour of Pleura: First Case Report.

Authors:  Anirban Das; Abhishek Pratap
Journal:  Case Rep Oncol Med       Date:  2016-02-29

7.  Efficacy of topotecan in pretreated metastatic poorly differentiated extrapulmonary neuroendocrine carcinoma.

Authors:  Leonidas Apostolidis; Frank Bergmann; Dirk Jäger; Eva Caroline Winkler
Journal:  Cancer Med       Date:  2016-07-25       Impact factor: 4.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.